Oncology Nutrition 2022 Symposium: Advances and Trends in Oncology Nutrition - Research Focus
Oncology Nutrition 2022 Symposium: Advances and Trends in Oncology Nutrition - Research Focus
0 item(s) Subtotal $0,00
Oncology Nutrition 2022 Symposium: Advances and Trends in Oncology Nutrition - Research Focus
Oncology Nutrition 2022 Symposium: Advances and Trends in Oncology Nutrition - Research Focus
This symposium was hosted live on June 10 - 12, 2022.
Come learn about cutting edge oncology nutrition from the leading experts in the field. This bundle of sessions is focused on the topic of Research.
Inconsistent malnutrition screening practices have contributed to a poor understanding of malnutrition risk among head and neck cancer patients receiving outpatient curative radiotherapy. These patients are not only at increased risk for malnutrition, but emerging evidence indicates they also suffer skeletal muscle loss (sarcopenia). Both the decline in nutritional status and the loss of muscle status negatively impacts treatment delivery and clinical outcomes. In the era of increased prevalence of overweight and obesity among cancer patients, it is difficult to determine the level of pretreatment weight or amount of unintentional weight loss that predicts malnutrition risk. Simple weight loss may not be a reliable predictor of need for nutrition intervention. In this pilot study, a validated malnutrition screening survey, Short Form Patient Generated Subjective Global Assessment (SF-PGSA), was completed by head and neck cancer patients undergoing radiation therapy at Roswell Park Comprehensive Cancer Center at the beginning and at the end of treatment. Change in muscle status for a sample of radiation treated head and neck cancer patients was also estimated using clinically available computed tomography (CT) scans. Patients suffered declines in both malnutrition risk and muscle mass from the beginning of treatment to the end of treatment (approximately 7 weeks) regardless of weight status. Changes in malnutrition risk by last treatment indicated a critical need for nutrition intervention and symptom management, yet most patients did not see a registered dietitian nutritionist. Results align with others reported in the literature indicating a need for change in nutrition and dietetic practice in outpatient oncology.
Speaker:
Mary Platek, PhD, MS, RD, CDN
D'Youville College
Roswell Park Comprehensive Cancer Center
This presentation will focus on the clinical RDN's role in research and, specifically, how to bridge research and clinical practice. Utilizing examples of the emerging evidence for the role of EN in the HCT population, diet recommendations for the neutropenic/immunosuppressed patients, impact of lean body mass on outcomes and metabolic syndrome as a Survivorship topic in the HCT population, this presentation will show that research can be done while practicing clinically and provides great value.
Speaker:
Kerry McMillen, MS, RD, CSO, FAND
Fred Hutchinson Cancer Center
Our overall goal is to discuss how care from a Registered Dietitian Nutritionist (RDN) can potentially improve treatment and medical outcomes for cancer patients in the outpatient setting.
Speakers:
Tricia Cox, MS, RD, CNSC, LD
Baylor Scott
White Health
Dolores Guest, PhD, RD
University of New Mexico
Through a biopsychosocial and culturally humble lens:
Speaker:
Celia Framson, MPH, RD, CSP
Children's Hospital Los Angeles
From seasonal specials celebrating commemorative events and awareness campaigns to sales on soon-to-expire CPE activities and book titles for which new editions are just around the corner, don't miss this opportunity to grab cutting-edge resources at discounted prices.